Latest News for: vrtx
Edit
Vertex Pharmaceuticals (VRTX): The Evolution of a Biotech Powerhouse in 2026
The Call 20 Mar 2026
VRTX) has officially transcended its long-held identity as "the cystic fibrosis (CF) company." ... Wall Street sentiment remains overwhelmingly "Bullish" or "Overweight" on VRTX.
Edit
Vertex Pharmaceuticals (VRTX) Stock Surges 5% Following Positive Kidney Disease Trial Results
BitRSS 10 Mar 2026
Vertex Pharmaceuticals (VRTX) stock climbed 5% after ...
Edit
Why Vertex Pharmaceuticals (VRTX) Stock Is Up Today
The Call 10 Mar 2026
What Happened?. Shares of biotech company Vertex Pharmaceuticals (NASDAQ. VRTX) jumped 8.3% in the afternoon session after the company announced positive results from a late-stage trial for its experimental kidney disease drug, povetacicept ... More News ... .
Edit
Final Trade: BSY, SHEL, VRTX, IGV
CNBC 06 Mar 2026
CNBC’s “Fast Money” team share their final trades of the day ... .
Edit
Vertex Pharmaceuticals’s (NASDAQ:VRTX) Q4 CY2025: Beats On Revenue
The Call 12 Feb 2026
VRTX) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 9.5% year on year to $3.19 billion ... Vertex Pharmaceuticals (VRTX) Q4 CY2025 Highlights. ... VRTX) develops and ...
Edit
VRTX JPM 2026 Presentation vFINAL (Vertex Pharmaceuticals Incorporated)
Public Technologies 12 Jan 2026
Edit
Vertex Pharmaceuticals (VRTX) Stock Trades Up, Here Is Why
The Call 06 Jan 2026
What Happened?. Shares of biotech company Vertex Pharmaceuticals (NASDAQ. VRTX) jumped 3.8% in the afternoon session after Wolfe Research upgraded the stock from "Peer Perform" to "Outperform" and issued a $548 price target ... More News. View More ... .
- 1